DNDNQ, was high as $54 a few years back. Its 'Provenge' is the only FDA approved drug in the sector (already sold for $300 M in 2014 and increasing). Lots of big pharm. companies are going to bid it in Feb. Very possible for the Commons to get $3-$4.